| [1] | 廖万清. 深部真菌感染治疗进展[J]. 中国麻风皮肤病杂志, 2003, 19(6):597-600. doi: 10.3969/j.issn.1009-1157.2003.06.036 |
| [2] | FRIDKIN SK, JARVIS WR. Epidemiology of nosocomial fungal infections[J]. Clin Microbiol Rev,1996,9(4):499-511. |
| [3] | PFALLER MA. Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission[J]. Clin Infect Dis,1996,22(Suppl 2):S89-S94. |
| [4] | LEE JS, JUNG WK, JEONG MH, et al. Sanguinarine induces apoptosis of HT-29 human colon cancer cells via the regulation of Bax/Bcl-2 ratio and caspase-9-dependent pathway[J]. Int J Toxicol,2012,31(1):70-77. doi: 10.1177/1091581811423845 |
| [5] | SANDAI D, TABANA YM, OUWEINI AE, et al. Resistance of Candida albicans biofilms to drugs and the host immune system[J]. Jundishapur J Microbiol,2016,9(11):e37385. |
| [6] | HARVEY AL, EDRADA ER, QUINN RJ. The re-emergence of natural products for drug discovery in the genomics era[J]. Nat Rev Drug Discov,2015,14(2):111-129. doi: 10.1038/nrd4510 |
| [7] | MORALES DK, JACOBS NJ, RAJAMANI S, et al. Antifungal mechanisms by which a novel Pseudomonas aeruginosa phenazine toxin kills Candida albicans in biofilms[J]. Mol Microbiol,2010,78(6):1379-1392. doi: 10.1111/j.1365-2958.2010.07414.x |